SOAT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.38529995755243E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.169200E-04 |
Normal-vs-Stage2 |
5.165600E-04 |
Normal-vs-Stage3 |
2.496200E-03 |
Normal-vs-Stage4 |
1.120400E-01 |
Stage1-vs-Stage2 |
7.704000E-03 |
Stage1-vs-Stage3 |
4.882200E-02 |
Stage1-vs-Stage4 |
3.896200E-01 |
Stage2-vs-Stage3 |
5.288600E-01 |
Stage2-vs-Stage4 |
3.948800E-01 |
Stage3-vs-Stage4 |
7.353800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.0278000006636E-08 |
Normal-vs-AfricanAmerican |
1.520410E-03 |
Normal-vs-Asian |
4.040000E-01 |
Caucasian-vs-AfricanAmerican |
2.558600E-01 |
Caucasian-vs-Asian |
8.266400E-01 |
AfricanAmerican-vs-Asian |
8.522400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.61979999600138E-08 |
Normal-vs-Female |
2.40569999998552E-06 |
Male-vs-Female |
3.785600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.161400E-03 |
Normal-vs-Extreme_Weight |
4.424100E-04 |
Normal-vs-Obese |
2.241000E-04 |
Normal-vs-Extreme_Obese |
4.237800E-01 |
Normal_Weight-vs-Extreme_Weight |
4.601200E-01 |
Normal_Weight-vs-Obese |
7.968400E-01 |
Normal_Weight-vs-Extreme_Obese |
1.081780E-01 |
Extreme_Weight-vs-Obese |
2.497400E-01 |
Extreme_Weight-vs-Extreme_Obese |
3.476200E-01 |
Obese-vs-Extreme_Obese |
5.402200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.144100E-02 |
Normal-vs-Age(41-60Yrs) |
9.02419999837534E-08 |
Normal-vs-Age(61-80Yrs) |
2.42989999998944E-06 |
Normal-vs-Age(81-100Yrs) |
4.070100E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.074000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.157000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.432800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.026200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.893600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.347600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.2234999999805E-06 |
Normal-VS-Type2 PRCC |
3.21940000003185E-06 |
Normal-VS-KIRP CIMP |
8.409500E-02 |
Normal-VS-Unclassified PRCC |
8.27820000000035E-05 |
Type1 PRCC-VS-Type2 PRCC |
7.670100E-02 |
Type1 PRCC-VS-KIRP CIMP |
8.128600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.003220E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.551810E-01 |
Type2 PRCC-VS-Unclassified PRCC |
9.930000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.662800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.140210E-03 |
Normal-vs-N1 |
4.357100E-03 |
Normal-vs-N2 |
1.360820E-01 |
N0-vs-N1 |
2.218800E-01 |
N0-vs-N2 |
3.775200E-01 |
N1-vs-N2 |
8.617600E-01 |
|
|